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Abstract
Background:  G-protein-coupled receptors (GPCRs) play a crucial role in many biological
processes and represent a major class of drug targets. However, purification of GPCRs for
biochemical study is difficult and current methods of studying receptor-ligand interactions involve
in vitro systems. Caenorhabditis elegans is a soil-dwelling, bacteria-feeding nematode that uses GPCRs
expressed in chemosensory neurons to detect bacteria and environmental compounds, making this
an ideal system for studying in vivo GPCR-ligand interactions. We sought to test this by functionally
expressing two medically important mammalian GPCRs, somatostatin receptor 2 (Sstr2) and
chemokine receptor 5 (CCR5) in the gustatory neurons of C. elegans.
Results: Expression of Sstr2 and CCR5 in gustatory neurons allow C. elegans to specifically detect
and respond to somatostatin and MIP-1α respectively in a robust avoidance assay. We demonstrate
that mammalian heterologous GPCRs can signal via different endogenous Gα subunits in C. elegans,
depending on which cells it is expressed in. Furthermore, pre-exposure of GPCR transgenic
animals to its ligand leads to receptor desensitisation and behavioural adaptation to subsequent
ligand exposure, providing further evidence of integration of the mammalian GPCRs into the C.
elegans sensory signalling machinery. In structure-function studies using a panel of somatostatin-14
analogues, we identified key residues involved in the interaction of somatostatin-14 with Sstr2.
Conclusion: Our results illustrate a remarkable evolutionary plasticity in interactions between
mammalian GPCRs and C. elegans signalling machinery, spanning 800 million years of evolution. This
in vivo system, which imparts novel avoidance behaviour on C. elegans, thus provides a simple means
of studying and screening interaction of GPCRs with extracellular agonists, antagonists and
intracellular binding partners.
Background
The nematode C. elegans represents a simple and experi-
mentally tractable multicellular organism, which has
been used to investigate many biological processes,
including chemosensory behaviour [1]. It uses only 11
pairs of amphid chemosensory neurons to detect environ-
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mental signals. As in mammalian systems, GPCRs play an
important role in the detection of sensory signals, and
these signals are relayed in the cell by heterotrimeric G
proteins. In contrast to mammalian chemosensory sys-
tems, the C. elegans sensory neurons express multiple
GPCRs in each sensory neuron using several Gα subunits
per neuron for sensory transduction, thus allowing the
nematode to respond specifically to different environ-
mental cues using only a few sensory neurons [2-4].
Current methods utilised to study mammalian GPCR-lig-
and interactions are mostly in vitro systems, which are not
always an accurate reflection of in vivo interactions. Given
that mammalian GPCRs are an important group of drug
targets, it would be an advantage to have an accessible in
vivo  system to investigate GPCR interactions with its
respective agonists and antagonists. Using C. elegans to
study in vivo GPCR-ligand interactions is an advantage
because functional expression of heterologous olfactory
receptors in the AWA and AWB olfactory neurons has pre-
viously been shown (Milani et al) [5] and our unpub-
lished observations. However, olfactory neurons are not
directly exposed to the environment, but are embedded in
the glial-like amphid sheath cells, making them inaccessi-
ble to non-volatile soluble ligands [1]. Critically, they are
inaccessible to most non-volatile soluble ligands, preclud-
ing the possibility of using such a system for identifying
drugs that affect GPCR activity. Hence, we set out to test
whether we would elicit ligand-dependent behavioural
responses in C. elegans by expressing mammalian GPCRs
in the ASH and ADL gustatory neurons, as they are directly
exposed to the environment allowing access of protein
and peptide ligands to the heterologous receptors. In
addition, the ASH and ADL neurons express a large variety
of Gα subunits [3], increasing the likelihood of GPCR-Gα
protein interaction. The nociceptive neurons, ASH and
ADL, drive repulsive responses, [6] and so receptor activa-
tion is reflected in an avoidance response on ligand expo-
sure, which can be analysed using robust behavioural
assays [7,8]. To test this, we chose to functionally express
two medically relevant GPCRs, Sstr2 and CCR5. Somato-
statin receptors bind two isoforms of a tetradecapeptide,
SST-14 and -28 [9,10]. Both have broad regulatory func-
tions, acting as neurotransmitters in the central and
peripheral nervous system and inhibitors of hormone
secretion [9,10]. CCR5 is a chemokine receptor that binds
MIP-1α (CCL3), MIP-1β (CCL4) and RANTES, and directs
chemotactic responses in leucocytes. This receptor is also
the route by which HIV-1 infection occurs, making this
receptor a therapeutic target in AIDS treatment [11].
Here we show that transgenic C. elegans expressing mam-
malian Sstr2 and CCR5 in the ASH and ADL nociceptive
neurons display specific and robust avoidance responses
to their respective ligands. The avoidance behaviour to
somatostatin in Sstr2 transgenic animals can be inhibited
using the somatostatin antagonist cyclosomatostatin. Fur-
thermore, pre-exposure of the GPCR transgenic animals to
their respective ligand abolishes this avoidance response
without affecting its avoidance behaviour towards other
repellent compounds. Heterologously expressed GPCRs
are able to signal via different endogenous Gα subunits
depending on which cells they are expressed in, indicating
that GPCRs and Gα proteins are largely conserved in their
interaction domains across highly diverged species.
Finally, we demonstrate the utility of this avoidance assay
by identifying the key residues involved in interaction of
somatostatin with its receptor.
Results
Transgenic animals expressing heterologous mammalian 
GPCRs are able to direct specific responses to agonists
To express mammalian GPCRs in the ASH and ADL noci-
ceptive neurons, we cloned the receptor genes down-
stream of the gpa-11 promoter, which drives expression in
these neuron pairs [3]. Following injection, transgenic
animals were visualised using a gut-expressed elt-2::GFP
construct, allowing selection of live transgenic animals
from mixed populations using a flow sorter (MoFlo)
modified with a 150-µm flow-cell tip (Figure 1A; see Addi-
tional file 1 and 2).
Sorted populations of Sstr2 and CCR5 transgenic animals
(denoted as gpa-11::sstr2 and gpa-11:ccr5 respectively in
figures) were tested for their response to the native ligands
using a soluble compound avoidance assay adapted from
Wicks et al [7]; (see Materials and methods). Wild type
and Sstr2 transgenic animals were tested for their response
to varying concentrations of SST-28. In contrast to wild-
type animals, Sstr2 transgenic animals exhibited avoid-
ance of SST-28 (Figure 1B). The strongest response was
observed with 25 µM SST-28. Ovine isolated SST-25 and
human SST-28 have previously been found to have higher
biological activity than SST-14 [12]. The behaviour of the
Sstr2 transgenic animals is consistent with this; SST-25
and SST-28 induced stronger avoidance responses than
SST-14 (Figures 1B, 4). As a control, we tested the
response of this strain to neurotensin and MIP-1α. Nei-
ther compounds elicited a response in the Sstr2 transgenic
animals, confirming specificity of GPCR-ligand interac-
tion (Figure 1B).
In order to confirm that other GPCRs could be expressed
functionally in C. elegans, we generated transgenic ani-
mals that express CCR5 in the ASH/ADL neurons. Trans-
genic strains were tested for avoidance of MIP-1α, SST-28
and neurotensin. CCR5 transgenic animals only showed
avoidance of MIP-1α, not of the control peptides (Figure
1C). An optimal avoidance response was obtained with
10 µM MIP-1α. In addition, we also expressed CCR5 inBMC Biology 2006, 4:22 http://www.biomedcentral.com/1741-7007/4/22
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Expression of mouse Sstr2 and human CCR5 in nociceptive neurons in C. elegans generates agonist specific avoidance behav- iour Figure 1
Expression of mouse Sstr2 and human CCR5 in nociceptive neurons in C. elegans generates agonist specific avoidance behav-
iour. (A) Flow sorting of transgenic nematodes expressing heterologous GPCRs and gut specific GFP marker (elt-2::GFP). 
Graph shows a plot of forward scatter (size) against GFP fluorescence intensity. GFP-positive animals are sorted into larval 
stages L1, L2 and L3 according to size with 90% purity and 95% viability (sort gates R1, R2 and R3 respectively). (B) Wild type 
and Sstr2 transgenic animals were tested with 1–50 µM of SST-28. As controls, the responses to 1% SDS, M9 diluent, the unre-
lated neuropeptides, neurotensin and MIP-1α were determined. Sstr2 transgenic animals did not avoid 25 µM cyclosomatosta-
tin. Both strains display a normal avoidance response to 1% SDS. Asterisks indicate a statistically significant difference between 
wild type and Sstr2 transgenic animals. (C) Avoidance responses of wild type and CCR5 transgenic animals to various concen-
trations of MIP-1α, M9 diluent, 1% SDS and 25 µM SST-28. Error bars denote the standard error of the mean. Asterisks indi-
cate a statistically significant difference between wild type and CCR5 transgenic animals. (D) Animals were either directly 
tested for their response to M9, SST-28 or 1% SDS or pre-incubated with 25 µM cyclosomatostatin (denoted cyclosst in fig-
ure) for 3 minutes before the assays. Pre-treatment with 25 µM cyclosomatostatin abolished the avoidance response of Sstr2 
transgenic animals to 25 µM SST-28. Avoidance responses can be recovered by an additional 5 minutes wash to remove cyclos-
omatostatin. Asterisks indicate a statistically significant difference between cyclosomatostatin treated and untreated transgenic 
animals. In all panels, each data point represents an average of at least five independent assays for wild-type and each respective 
strain. Error bars denote the standard error of the mean. (*p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.005). Avoidance index = number of 
worms behind barrier/total number of wormsBMC Biology 2006, 4:22 http://www.biomedcentral.com/1741-7007/4/22
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the ASH neurons using the sra-6 promoter, which also
gave a robust avoidance response to 25 µM MIP-1α(Figure
2C). This demonstrates that mammalian GPCR expres-
sion in the ASH neurons is sufficient to generate avoid-
ance behaviour to its ligands. We also tested the response
of the Sstr2 and CCR5 transgenic animals to SST-28 and
MIP-1α using the dry-drop test [8]. The average frequency
of avoidance for each tested compound in this single ani-
mal assay was very similar to that in the population assay
(Additional file 3).
The ASH and ADL neurons of C. elegans normally direct
avoidance responses to environmental agents such as low
pH and sodium dodecyl sulphate (SDS) [6]. When
exposed to a barrier of 1% SDS, neither transgenic strain
crossed the barrier, suggesting that normal avoidance
behaviour is unaffected by expression of heterologous
GPCRs. We have thus shown that expression of mamma-
lian GPCRs in transgenic animals generates a specific
avoidance response towards its respective agonists.
Sstr2 antagonist, cyclosomatostatin can inhibit response of 
Sstr2 transgenic animals to somatostatin
To analyse the specificity of ligand-receptor interaction
reflected in the avoidance response, Sstr2 transgenic ani-
mals were tested with a competitive somatostatin antago-
nist, cyclosomatostatin [cyclo(D-Trp-Lys-Thr-Ahep-Phe)],
which blocks somatostatin binding to its receptors [13].
Pre-exposure of Sstr2 transgenic animals to 10 µM of
cyclosomatostatin in liquid for 3 minutes eliminated
most of the avoidance behaviour towards 25 µM SST-28
(Figure 1D). Higher concentrations of cyclosomatostatin
and longer incubation times tend to cause paralysis in
both wild-type and transgenic animals (results not
shown). We also tested for reversibility of this antagonis-
tic effect by allowing the worms to recover for 5 minutes
by washing them after the 3 minute pre-incubation step.
The resulting effect was a recovery of the Sstr2 transgenic
animals' avoidance behaviour to SST-28 (Figure 1D).
Hence, the avoidance response to SST-28 could be
restored in 5 minutes after antagonist pre-exposure.
Mammalian heterologous GPCRs can signal via different 
endogenous Gα subunits in C. elegans
Our results confirm that the biological properties of the
GPCRs can be translated into the altered sensory behav-
iour of the transgenic animals, suggesting that heterolo-
gous GPCRs use C. elegans signal transduction in
nociceptive neurons. gpa-11 is expressed predominantly
in ADL neurons, and to a lesser extent in ASH neurons [3].
The ASH and ADL neurons express a variety of Gα pro-
teins. Little is known about the molecules used in the ADL
cells. Nociceptive signalling in ASH involve the Gα pro-
teins ODR-3 [14] and GPA-3 [15]. These in turn lead to
downstream activation of TRPV calcium-channel OSM-9
or OCR-2 [16,17]. To identify some of the molecules
involved, we tested several mutants known to affect avoid-
ance behaviour. Inactivation of osm-9 or gpa-3 fully abol-
ished the response to SST-28 and MIP-1α in Sstr2 and
CCR5 transgenic animals respectively, whereas inactiva-
tion of odr-3 did not (Figure 2A and 2B). These results
indicate that the heterologous GPCRs, expressed predom-
inantly in the ADL signals via GPA-3 to activate OSM-9. In
contrast, the avoidance response to MIP-1α of sra-6::ccr5
animals expressing CCR5 predominantly in the ASH neu-
rons (with a low level in ASI) were not affected by removal
of  gpa-3  or  odr-3  (Figure 2C) [18]. Given that sra-6  is
weakly expressed in ASI that mediates attraction behav-
iour, this may have a subtle effect on avoidance mediated
by the ASI neurons, although is unlikely to affect the
avoidance behaviour of the transgenic animals towards its
ligands. Our results indicate that CCR5 can activate differ-
ent C. elegans Gα subunits, depending in which cells it is
expressed in. In ASH neurons, CCR5 could signal redun-
dantly via GPA-3 or ODR-3 or any of the other Gα subu-
nits present in these neurons. These results illustrate a
level of promiscuity in the interactions between heterolo-
gous GPCRs and the endogenous signalling components
of C. elegans.
Pre-exposure to native agonists causes receptor 
desensitisation and adaptation behaviour in Sstr2 and 
CCR5 transgenic animals
Activation of GPCRs in both worms and mammals even-
tually leads to receptor desensitisation through phospho-
rylation by GPCR kinases (GRKs) and arrestins [19-21].
To study whether the response of the Sstr2 and CCR5
transgenic animals to their respective ligands was subject
to desensitisation (leading to adaptation), the animals
were pre-exposed to either 1 µM or 10 µM of the respective
peptides in liquid for 10 minutes in liquid before testing
the avoidance response. The avoidance behaviour of Sstr2
transgenic animals in response to 25 µM SST-28 was
strongly reduced after pre-exposure to 1 µM SST-28,
whereas pre-exposure to 10 µM SST-28 could fully abolish
avoidance of SST-28 (Figure 3A). The avoidance behav-
iour to other repellents such as 1% SDS was not affected
by the pre-exposure to SST-28, suggesting that SST-28
adaptation is independent from the pathway that signals
avoidance of 1% SDS. Similarly, CCR5 transgenic animals
were pre-exposed to 1 µM and 10 µM of MIP-1α and
tested at three different MIP-1α concentrations. Full adap-
tation to MIP-1α was achieved with both pre-exposure
concentrations; however, pre-exposure did not affect
other avoidance responses (Figure 3B). These results dem-
onstrate that avoidance of SST-28 and MIP-1α mediated
by their respective mammalian GPCRs in C. elegans is sub-
ject to specific adaptation. We propose that the C. elegans
signalling components involved in receptor desensitisa-
tion interact with the heterologous GPCRs.BMC Biology 2006, 4:22 http://www.biomedcentral.com/1741-7007/4/22
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Heterologously expressed GPCRs are integrated into an endogenous signalling pathway in C. elegans Figure 2
Heterologously expressed GPCRs are integrated into an endogenous signalling pathway in C. elegans. Mutation of the TRPV 
channel subunit osm-9 and the Gα subunit gpa-3 fully abolished avoidance of (A) 25 µM SST-28 in Sstr2 transgenic animals and 
(B) 25 µM MIP-1α in CCR5 transgenic animals. Mutation of Gα subunit odr-3 did not affect these responses. (C) In contrast, 
mutation of either gpa-3 or odr-3 did not have a significant effect on avoidance response in sra6::CCR5 transgenic animals. Each 
data point represents an average of at least 3 independent assays for wild type and each respective strain. Error bars denote 
the standard error of the mean. Asterisks indicate a statistically significant difference between osm-9 or gpa-3 mutant animals 
and wild type animals carrying the Sstr2 or CCR5 transgenes (*p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.005).BMC Biology 2006, 4:22 http://www.biomedcentral.com/1741-7007/4/22
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Trp8 and Lys9 of SST-14 are essential for Sstr2 activation
Given that heterologous GPCRs can be expressed func-
tionally in nociceptive neurons, we sought to investigate
the structure-function relationship by screening SST-14
analogues. Structure activity studies on SST-14 have sug-
gested that the amino-acid residues Phe7, Trp8, Lys9 and
Thr10 are important in receptor-ligand interaction, with
Trp8 and Lys9 being essential, whereas Phe7 and Thr10
can undergo minor conserved substitutions [22]. We
investigated the role of these residues by testing the five
peptides analogues, where residues 6–10 of SST-14 are
individually substituted with Ala. The Sstr2 transgenic
animals showed a completely attenuated response
towards the Trp8∆ Ala and Lys9∆ Ala analogues, whereas
partial avoidance responses were observed to both Phe7∆
Ala and Thr10∆ Ala (Figure 4). No significant difference in
avoidance response was observed with Phe6∆ Ala, indicat-
ing that this residue is not essential for receptor-ligand
interaction.
Discussion
G protein coupled receptors (GPCRs) represent the largest
and most diverse family of proteins in the human genome
[23]. Given that this family of proteins play key roles in
many biological processes, they constitute one of the prin-
cipal targets for drug development. The C. elegans sensory
system is exceptionally well suited for heterologous GPCR
expression given that each neuron expresses multiple
endogenous GPCRs [2]. Furthermore, multiple Gα subu-
nits are expressed in each chemosensory neuron [3] allow-
ing cross-talk between a single GPCR and potentially
multiple Gα proteins. Moreover, the gustatory neurons are
exposed to the external environment, making it accessible
to water-soluble ligands. Here we show that expression of
heterologous GPCRs in gustatory neurons under the con-
trol of two different promoters, gpa-11 (ADL and ASH
expression) and sra-6 (ASH expression with weak expres-
sion in ASI), can drive repulsive responses to the respec-
tive ligands presented in soluble pure form. The
behavioural response to the ligands can be tested using
robust avoidance assays, making this an ideal in vivo sys-
tem to study receptor-ligand interactions. Sstr2 and CCR5
transgenic animals were able to specifically avoid the
respective agonists without affecting avoidance behaviour
towards other repellents. Similar responses were observed
in multiple transgenic strains with different promoters
using both the population and single-animal avoidance
assays. The fidelity of the system extends to antagonists, as
pre-exposure of Sstr2 transgenic animals to a somatostatin
antagonist, cyclosomatostatin, inhibited avoidance
response to somatostatin. The antagonistic effect was
reversible given that the avoidance behaviour could be
recovered by washing the transgenic animals. This pro-
vides further evidence for specific receptor-ligand interac-
tion.
It has previously been shown that widespread promiscuity
occurs in the interactions of mammalian GPCRs with
mammalian Gα proteins [23,24]. Our results demonstrate
that mammalian GPCRs integrate into the normal endog-
Sstr2 and CCR5 transgenic animals mutants are desensitised by pre-exposure to agonists Figure 3
Sstr2 and CCR5 transgenic animals mutants are desensitised by pre-exposure to agonists. (A) Pre-exposure of Sstr2 transgenic 
animals to 1 µM and 10 µM SST-28 prior to the assay strongly reduced or even abolished avoidance behaviour. (B)Pre-expo-
sure of CCR5 transgenic animals to 1 µM and 10 µM MIP-1α fully abolished avoidance of 1 µM, 10 µM and 25 µM MIP-1α. In 
both cases, pre-exposure to the agonist did not affect the responses towards other repellents. Animals were washed in buffer 
as control. For each panel, each data point represents an average of at least five independent assays for wild type and each 
respective strain. Error bars denote the standard error of the mean. Asterisks indicate a statistically significant difference 
between transgenic animals pre-exposed to agonist or only to chemotaxis (CTX) buffer (*p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.005).BMC Biology 2006, 4:22 http://www.biomedcentral.com/1741-7007/4/22
Page 7 of 9
(page number not for citation purposes)
enous Gα protein signalling pathway in the worm, show-
ing a remarkable evolutionary plasticity in these
interactions, spanning 800 million years [25]. Rat Sstr2
has previously been demonstrated to interact with endog-
enous yeast Gα protein, Gpa1p, when the receptor was
expressed in Sacchromyces cerevisiae, which provides fur-
ther evidence that G proteins across highly diverged spe-
cies are largely conserved in their interaction domains
[26]. Moreover, functional expression of mammalian bit-
ter-taste receptors (of the T2R family) and TRPV (VR1)
channels in ASI and ASH neurons have been reported,
supporting the suitability of C. elegans as a heterologous
expression system [17,27]. In this paper, we show that
several Gα proteins are involved in downstream signalling
in the ASH neurons. Given the abundance of Gα proteins
in these neurons, it would be interesting to examine the
individual roles of Gα proteins involved in signalling with
heterologous GPCRs.
Attenuation of GPCR signalling by GRKs and arrestins is
important for an organism to maintain a homeostatic cel-
lular environment [19-21]. Desensitisation also ensures
that receptors are ready for the next coming wave of input
stimuli. We found that pre-exposure to varying concentra-
tions of the ligand leads to adaptation of the response to
the ligand but not to other repellents. This suggests that
the heterologously expressed mammalian GPCRs in C.
elegans are subjected to desensitisation by the endogenous
machinery, further supporting the notion that heterolo-
gous GPCRs are integrated into the endogenous signalling
pathway.
The system for heterologous expression of functional
GPCRs in C. elegans described here provides a novel
means of screening for agonists and antagonists, and for
carrying out structure function studies on GPCRs and
their ligands. To illustrate this potential, we measured
receptor activation on a series of SST-14 mutant peptides,
in which amino acids at positions 6–10 were individually
changed to alanine. The avoidance response to Trp8∆ Ala
and Lys9∆ Ala SST-14 analogues was abolished while
reduced avoidance behaviour was found with Phe7∆ Ala
and Thr10∆ Ala. Sstr2 transgenic animals were repelled by
the Phe6∆ Ala analogue, indicating that Phe6 is not essen-
tial for receptor-ligand interaction. This work confirmed
and extended the previous finding, based on activity of
hexapeptide analogues, that residues 7–10 contain key
elements necessary for its biological activity of somatosta-
tin [13]. This illustrates the practical utility of this system
for identifying structure-function relationships and for
screening soluble compounds by measuring behavioural
responses in GPCR transgenic animals.
Conclusion
Our work describes the generation of novel behavioural
response in C. elegans to exogenous human ligands. This
provides a powerful platform for exploring GPCR-ligand
interactions in an animal model in vivo. Furthermore, the
'synthetic' response holds potential in basic studies of
behaviour and higher learning in C. elegans. By exploiting
the gustatory chemosensory system in C. elegans, we have
developed a novel and rapid assay to study interaction of
medically important receptors with both extracellular and
intracellular partners and drug candidates.
Methods
Strains and plasmids
Nematodes were grown at 16°C or 20°C on E. Coli strain
OP50 using standard methods [28]. Wild-type animals
were C. elegans variety Bristol strain N2. Strains used in
this study are odr-3(n1605), gpa-3(pk35) and osm-9(ky10).
Reagents
SST-14, -28, -25 and its analogues were purchased from
Bachem, UK. MIP-1α was obtained from GeneFlow, UK.
Peptides were dissolved in M9.
Identification of SST-14 residues involved in Sstr2 activation Figure 4
Identification of SST-14 residues involved in Sstr2 activation. 
Sstr-2 transgenic animals were tested for response to SST-14 
and five variants with single alanine substitutions at residues 
6–10. No avoidance behaviour was observed with 25 µM of 
Trp8∆ Ala and Lys9∆ Ala SST-14 analogues while residual 
avoidance behaviour was found with Phe7∆ Ala and Thr10∆ 
Ala. Sstr2 transgenic animals were repelled by the Phe6∆ Ala 
analogue, indicating that Phe6 is not essential for receptor:lig-
and interaction. Each data point represents an average of at 
least five independent assays for wild type and each respec-
tive strain. Error bars denote the standard error of the 
mean. Asterisks indicate a statistically significant difference 
between the avoidance index of the transgenic animals for 
the Trp8∆ Ala and Lys9∆ Ala analogues and native SST-14 
agonist (*p ≤ 0.05, **p ≤ 0.01).BMC Biology 2006, 4:22 http://www.biomedcentral.com/1741-7007/4/22
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Molecular biology
Full-length mouse Sstr2 and human CCR5 were cloned
downstream of a 1.5 kb fragment of the gpa-11 promoter
into pUC119. The 3' UTR of unc-54 was cloned down-
stream of both genes. The fragment containing CCR5 and
the unc-54 3'UTR was subcloned into an sra-6::GFP con-
struct.
Transgenic strains
Germ line transformation was carried out as described by
Mello  et al. [29] using 40 ng/µl of gpa-11::sstr2,  gpa-
11::ccr5 with 100 ng/µl of elt-2:gfp plasmid, or 100 ng/µl
of sra-6::ccr5 with 25 ng/µl of elt-2:gfp [30]. As the trans-
genic animals carry non-integrated arrays that could cause
a degree of fluctuation in the assay, at least three trans-
genic strains were tested before picking out the best
responding strain for repeating assays. For the mutant
analysis, the best responding non-integrated strain was
crossed with osm-9(ky10),  gpa-3(pk35),  odr-3(n1605)
mutant. The mutant alleles were traced by PCR. At least
three transgenic strains were tested before picking out the
best responding strain for repeating assays.
FACS sorting conditions
Animals were washed with M9 and filtered through a 100-
µm mesh filter. Appropriate sorting of each developmen-
tal stage was verified using epifluorescence microscopy.
The animals were then grown for a day prior to testing in
a soluble compound avoidance assay (see Additional file
1 for more details).
Soluble compound avoidance assay
Mutant avoidance behaviour was assessed on rectangular
four-well plates (Nunclon, UK) using an assay adapted
from Wicks et al. [7]. This reduces the amount of avoid-
ance compound used. Each compartment was filled with
12 ml CTX agar (2 % agar, 5 mM potassium phosphate
buffer (pH 6.6), 1 mM CaCl2, 1 mM MgSO4). A thin line
of the soluble ligand was applied across one end of the
well about 25 mm from the end of the plate (note that the
ligand concentrations given here are the applied concen-
trations for the assay). Adult animals were washed three
times in CTX buffer (5 mM potassium phosphate buffer
(pH 6.6), 1 mM CaCl2, 1 mM MgSO4). When the test com-
pound was absorbed into the agar, about 50 animals were
placed 10 mm behind the line of the compound in about
5 µl of CTX buffer. A volatile attractant, 1:10 benzalde-
hyde, was added to the opposite end of the plate. The
avoidance index was calculated by counting the number
of worms that did not crawl past the boundary after 30
minutes, divided by the total number of worms applied.
The assay was performed for 30 minutes as the avoidance
index did not change significantly after 30–50 minutes
into the assay. Avoidance index = number of worms
behind barrier/total number of worms
Statistical analysis
Statistical analysis of behavioural data was performed
using the paired Student's t-test. If multiple groups were
tested, statistical significance was determined by ANOVA.
An α level of 0.05 was used in all tests. All results are given
as mean ± SEM
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